close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about RMTI

Recent news which mentions RMTI

< Previous 1 2 3 4 Next >
The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data
Tickers ABVC ACAD ACET ADMA
Tags GBT MCRB IFRX
From Benzinga
The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline
Tickers ABBV ABSI ABVC ACAD
Tags DFFN NKTR SCPS
From Benzinga
Stocks That Hit 52-Week Lows On Tuesday
Tickers ONCS ONEM ORTX OSCR
Tags TLMD PBLA ONEM
From Benzinga
The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business
Tickers ABSI ABVC ACAD ACHV
Tags SPRB RMD TLSA
From Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Tickers CYCN FBRX HQY NAOV
Tags QLGN CYCN NAOV
From Benzinga
Recap: Rockwell Medical Q2 Earnings
Tickers RMTI
Tags BZI/Recaps Benzinga Earnings
From Benzinga
7 Penny Stocks to Buy if You Want Potential Multibaggers
Tickers ACB CGC COE CRNT
Tags GRNWF Market News ACB
From InvestorPlace
Stocks That Hit 52-Week Lows On Monday
Tickers IRCP JRJC JUPW KNSA
Tags Market News RAAS UTME
From Benzinga
Earnings Scheduled For August 16, 2021
Tickers ACRX ACTG AESE AG
Tags VBLT Earnings VYNT
From Benzinga
The Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPO
Tickers ABVC ACAD ACHL ADGI
Tags BPTH ALKS TXMD
From Benzinga
The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma
Tickers ABCL ACET ACHV ADGI
Tags SYBX CELU EWTX
From Benzinga
The Daily Biotech Pulse: Dicerna Slips On Data, Novavax Tightlipped On US Vaccine Approval, Adagio IPO
Tickers ACAD ACXP ADGI AKRO
Tags ATNX AUPH NVO
From Benzinga
Stocks That Hit 52-Week Lows On Thursday
Tickers AKRO AMED ARVL ATAI
Tags BAX CPB BLSA
From Benzinga
The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO
Tickers ABSI ABUS ACAD ACXP
Tags ASRT RVNC INVA
From Benzinga
The Daily Biotech Pulse: Pfizer, Bristol-Myers Squibb Earnings, Amgen Goes Shopping, GlaxoSmithKline-Vir's COVID-19 Antibody Treatment Supply Deal
Tickers ABCL ABOS ACET ACHL
Tags AMGN CTMX TRVN
From Benzinga
Stocks That Hit 52-Week Lows On Tuesday
Tickers MDGL ME MF MIRM
Tags NERV UPC NISN
From Benzinga
The Daily Biotech Pulse: ObsEva Surges On Out-Licensing Deal, EyeGate Appoints New CEO, 2 Positive Catalysts For Merck, Candel Therapeutics Debuts
Tickers ABCL ABSI ACET ACHL
Tags TCRR DAWN CASI
From Benzinga
The Daily Biotech Pulse: Ardelyx Sinks On Regulatory Setback, AnPac Issues Positive Preannouncement, European Nod For Myovant, HCW Biologics Debuts On Wall Street
Tickers ABIO ADAP ADVM AGRX
Tags GNFT TXMD KMDA
From Benzinga
The Daily Biotech Pulse: Moderna To Join S&P 500 Index, Thumbs Down For FibroGen's Anemia Drug, Corvus Shelves COVID Study
Tickers ABCL ACET ACHL ADAP
Tags TRVI CERS MRNA
From Benzinga
Stocks That Hit 52-Week Lows On Thursday
Tickers ORTX OTIC PASG PATH
Tags VEV UNCY 52/Week Lows
From Benzinga
The Daily Biotech Pulse: Lilly, Morphic's Positive Data At ECCO, Humanigen's COVID Treatment Gets Expedited Review In UK, TransCode IPO
Tickers ABCL ACET ACHL ADMA
Tags QURE MNOV AVTE
From Benzinga
The Daily Biotech Pulse: Priority Review For Amgen's Asthma Treatment, Evaxion Reports Positive Skin Cancer Readout, Quidel Recalls Lyra COVID-19 Test
Tickers ABCL ACHL ADVM AKUS
Tags IMV FDA BOLT
From Benzinga
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today